Citation: D. Vaknin et al., On the possibility of antiferromagnetic vortex cores in superconducting YBa2Cu3O7-delta, PHYSICA C, 329(2), 2000, pp. 109-113
Authors:
Kaufmann, M
Bajetta, E
Dirix, LY
Fein, LE
Jones, SE
Zilembo, N
Dugardyn, JC
Nasurdi, C
Mennel, RG
Cervek, J
Fowst, C
Polli, A
di Salle, E
Arkhipov, A
Piscitelli, G
Miller, LL
Massimini, G
Citation: M. Kaufmann et al., Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: Results of a phase III randomized double-blind trial, J CL ONCOL, 18(7), 2000, pp. 1399-1411
Authors:
Haffner, S
Olson, CG
Miller, LL
Lynch, DW
Citation: S. Haffner et al., Evidence for a strong impact of the electron-photon matrix element on angle-resolved photoelectron spectra of layered cuprate compounds, PHYS REV B, 61(21), 2000, pp. 14378-14381
Citation: Jg. Slatter et al., Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following i.v. infusion of [C-14]CPT-11 in cancer patients, DRUG META D, 28(4), 2000, pp. 423-433
Authors:
Eshel, M
Bino, A
Felner, I
Johnston, DC
Luban, M
Miller, LL
Citation: M. Eshel et al., Polynuclear chromium(III) carboxylates. 1. Synthesis, structure, and magnetic properties of an octanuclear complex with a ring structure, INORG CHEM, 39(7), 2000, pp. 1376-1380
Citation: Ll. Miller, Taking it to the streets - Reframing crime prevention through race and community, STUDIES IN LAW, POLITICS, AND SOCIETY, VOL 20, 2000, pp. 207-238
Authors:
Janik, JE
Miller, LL
Kopp, WC
Taub, DD
Dawson, H
Stevens, D
Kostboth, P
Curti, BD
Conlon, KC
Dunn, BK
Donegan, SE
Ullrich, R
Alvord, WG
Gause, BL
Longo, DL
Citation: Je. Janik et al., Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients, CLIN IMMUNO, 93(3), 1999, pp. 209-221
Authors:
Miller, LL
Pellock, JM
Boggs, JG
DeLorenzo, RJ
Meyer, JM
Corey, LA
Citation: Ll. Miller et al., Epilepsy and seizure occurrence in a population-based sample of Virginian twins and their families, EPILEPSY R, 34(2-3), 1999, pp. 135-143
Citation: J. Rader et al., Individualized wheelchair seating: Reducing restraints and improving comfort and function, TOP GERI RE, 15(2), 1999, pp. 34-47
Citation: Rf. Devore et al., Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer, J CL ONCOL, 17(9), 1999, pp. 2710-2720
Authors:
Friedman, HS
Petros, WP
Friedman, AH
Schaaf, LJ
Kerby, T
Lawyer, J
Parry, M
Houghton, PJ
Lovell, S
Rasheed, K
Cloughsey, T
Stewart, ES
Colvin, OM
Provenzale, JM
McLendon, RE
Bigner, DD
Cokgor, I
Haglund, M
Rich, J
Ashley, D
Malczyn, J
Elfring, GL
Miller, LL
Citation: Hs. Friedman et al., Irinotecan therapy in adults with recurrent or progressive malignant glioma, J CL ONCOL, 17(5), 1999, pp. 1516-1525
Authors:
Drengler, RL
Kuhn, JG
Schaaf, LJ
Rodriguez, GI
Villalona-Calero, MA
Hammond, LA
Stephenson, JA
Hodges, S
Kraynak, MA
Staton, BA
Elfring, GL
Locker, PK
Miller, LL
Von Hoff, DD
Rothenberg, ML
Citation: Rl. Drengler et al., Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors, J CL ONCOL, 17(2), 1999, pp. 685-696
Citation: S. Kondo et al., Synthesis, characterization, and magnetic susceptibility of the heavy-fermion transition-metal oxide LiV2O4, PHYS REV B, 59(4), 1999, pp. 2609-2626